Celgene Corporation, Eli Lilly and GE are set to invest $40m in a $100m biotech investment fund being established by New York City.

Early-stage biotech investor 5AM ready to roll on new fund worth $250m.

A venture capital initiative to launch more life science firms in New York City attracts more backers.

Veolia Environnement and LADEC, a development agency for the Lahti region of Finland, launch the Nordic Innovation Accelerator to fast-track Nordic cleantech companies into international markets.

Pharmaceutical company Celgene Corporation is collaborating with Versant Ventures' biotech incubator Blueline Bioscience to develop biotech startups in Toronto, Canada.